Posts

Showing posts with the label Global Proteomics Market

Proteomics Market: Industry Trends, Segments, Analysis and Forecast – 2030

Proteomics Market Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. The Global Proteomics Market is anticipated to hold a market value of USD 64.19 billion in 2030 and is expected to grow at a CAGR of 12.3% during the forecast period. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflow

Proteomics Market, Opportunities, Size, Share, Trends Analysis and Forecast to 2030

  Proteomics Market Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. The Global  Proteomics Market  is anticipated to hold a market value of  USD 108907.44 million in 2030  and is expected to grow at a CAGR of 16.30% during the forecast period. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics work